Cargando…

An approach to quantifying abnormalities in energy expenditure and lean mass in metabolic disease

BACKGROUND/OBJECTIVES: The objective of this study was to develop approaches to expressing resting energy expenditure (REE) and lean body mass (LM) phenotypes of metabolic disorders in terms of Z-scores relative to their predicted healthy values. SUBJECTS/METHODS: Body composition and REE were measu...

Descripción completa

Detalles Bibliográficos
Autores principales: Watson, L P E, Raymond-Barker, P, Moran, C, Schoenmakers, N, Mitchell, C, Bluck, L, Chatterjee, V K, Savage, D B, Murgatroyd, P R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3916834/
https://www.ncbi.nlm.nih.gov/pubmed/24281313
http://dx.doi.org/10.1038/ejcn.2013.237
_version_ 1782302768235544576
author Watson, L P E
Raymond-Barker, P
Moran, C
Schoenmakers, N
Mitchell, C
Bluck, L
Chatterjee, V K
Savage, D B
Murgatroyd, P R
author_facet Watson, L P E
Raymond-Barker, P
Moran, C
Schoenmakers, N
Mitchell, C
Bluck, L
Chatterjee, V K
Savage, D B
Murgatroyd, P R
author_sort Watson, L P E
collection PubMed
description BACKGROUND/OBJECTIVES: The objective of this study was to develop approaches to expressing resting energy expenditure (REE) and lean body mass (LM) phenotypes of metabolic disorders in terms of Z-scores relative to their predicted healthy values. SUBJECTS/METHODS: Body composition and REE were measured in 135 healthy participants. Prediction equations for LM and REE were obtained from linear regression and the range of normality by the standard deviation of residuals. Application is demonstrated in patients from three metabolic disorder groups (lipodystrophy, n=7; thyrotoxicosis, n=16; and resistance to thyroid hormone (RTH), n=46) in which altered REE and/or LM were characterised by departure from the predicted healthy values, expressed as a Z-score. RESULTS: REE (kJ/min)=−0.010 × age (years)+0.016 × FM (kg)+0.054 × fat-free mass (kg)+1.736 (R(2)=0.732, RSD=0.36 kJ/min). LM (kg)=5.30 × bone mineral content (kg)+10.66 × height(2) (m)+6.40 (male). LM (kg)=0.20 × fat (kg)+14.08 × height(2) (m)−2.93 (female). (male R(2)=0.55, RSD=3.90 kg; female R(2)=0.59, RSD=3.85 kg). We found average Z-scores for REE and LM of 1.77 kJ/min and −0.17 kg in the RTH group, 5.82 kJ/min and −1.23 kg in the thyrotoxic group and 2.97 kJ/min and 4.20 kg in the LD group. CONCLUSION: This approach enables comparison of data from individuals with metabolic disorders with those of healthy individuals, describing their departure from the healthy mean by a Z-score.
format Online
Article
Text
id pubmed-3916834
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-39168342014-02-07 An approach to quantifying abnormalities in energy expenditure and lean mass in metabolic disease Watson, L P E Raymond-Barker, P Moran, C Schoenmakers, N Mitchell, C Bluck, L Chatterjee, V K Savage, D B Murgatroyd, P R Eur J Clin Nutr Original Article BACKGROUND/OBJECTIVES: The objective of this study was to develop approaches to expressing resting energy expenditure (REE) and lean body mass (LM) phenotypes of metabolic disorders in terms of Z-scores relative to their predicted healthy values. SUBJECTS/METHODS: Body composition and REE were measured in 135 healthy participants. Prediction equations for LM and REE were obtained from linear regression and the range of normality by the standard deviation of residuals. Application is demonstrated in patients from three metabolic disorder groups (lipodystrophy, n=7; thyrotoxicosis, n=16; and resistance to thyroid hormone (RTH), n=46) in which altered REE and/or LM were characterised by departure from the predicted healthy values, expressed as a Z-score. RESULTS: REE (kJ/min)=−0.010 × age (years)+0.016 × FM (kg)+0.054 × fat-free mass (kg)+1.736 (R(2)=0.732, RSD=0.36 kJ/min). LM (kg)=5.30 × bone mineral content (kg)+10.66 × height(2) (m)+6.40 (male). LM (kg)=0.20 × fat (kg)+14.08 × height(2) (m)−2.93 (female). (male R(2)=0.55, RSD=3.90 kg; female R(2)=0.59, RSD=3.85 kg). We found average Z-scores for REE and LM of 1.77 kJ/min and −0.17 kg in the RTH group, 5.82 kJ/min and −1.23 kg in the thyrotoxic group and 2.97 kJ/min and 4.20 kg in the LD group. CONCLUSION: This approach enables comparison of data from individuals with metabolic disorders with those of healthy individuals, describing their departure from the healthy mean by a Z-score. Nature Publishing Group 2014-02 2013-11-27 /pmc/articles/PMC3916834/ /pubmed/24281313 http://dx.doi.org/10.1038/ejcn.2013.237 Text en Copyright © 2014 Macmillan Publishers Limited http://creativecommons.org/licenses/by-nc-nd/3.0/ This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/
spellingShingle Original Article
Watson, L P E
Raymond-Barker, P
Moran, C
Schoenmakers, N
Mitchell, C
Bluck, L
Chatterjee, V K
Savage, D B
Murgatroyd, P R
An approach to quantifying abnormalities in energy expenditure and lean mass in metabolic disease
title An approach to quantifying abnormalities in energy expenditure and lean mass in metabolic disease
title_full An approach to quantifying abnormalities in energy expenditure and lean mass in metabolic disease
title_fullStr An approach to quantifying abnormalities in energy expenditure and lean mass in metabolic disease
title_full_unstemmed An approach to quantifying abnormalities in energy expenditure and lean mass in metabolic disease
title_short An approach to quantifying abnormalities in energy expenditure and lean mass in metabolic disease
title_sort approach to quantifying abnormalities in energy expenditure and lean mass in metabolic disease
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3916834/
https://www.ncbi.nlm.nih.gov/pubmed/24281313
http://dx.doi.org/10.1038/ejcn.2013.237
work_keys_str_mv AT watsonlpe anapproachtoquantifyingabnormalitiesinenergyexpenditureandleanmassinmetabolicdisease
AT raymondbarkerp anapproachtoquantifyingabnormalitiesinenergyexpenditureandleanmassinmetabolicdisease
AT moranc anapproachtoquantifyingabnormalitiesinenergyexpenditureandleanmassinmetabolicdisease
AT schoenmakersn anapproachtoquantifyingabnormalitiesinenergyexpenditureandleanmassinmetabolicdisease
AT mitchellc anapproachtoquantifyingabnormalitiesinenergyexpenditureandleanmassinmetabolicdisease
AT bluckl anapproachtoquantifyingabnormalitiesinenergyexpenditureandleanmassinmetabolicdisease
AT chatterjeevk anapproachtoquantifyingabnormalitiesinenergyexpenditureandleanmassinmetabolicdisease
AT savagedb anapproachtoquantifyingabnormalitiesinenergyexpenditureandleanmassinmetabolicdisease
AT murgatroydpr anapproachtoquantifyingabnormalitiesinenergyexpenditureandleanmassinmetabolicdisease
AT watsonlpe approachtoquantifyingabnormalitiesinenergyexpenditureandleanmassinmetabolicdisease
AT raymondbarkerp approachtoquantifyingabnormalitiesinenergyexpenditureandleanmassinmetabolicdisease
AT moranc approachtoquantifyingabnormalitiesinenergyexpenditureandleanmassinmetabolicdisease
AT schoenmakersn approachtoquantifyingabnormalitiesinenergyexpenditureandleanmassinmetabolicdisease
AT mitchellc approachtoquantifyingabnormalitiesinenergyexpenditureandleanmassinmetabolicdisease
AT bluckl approachtoquantifyingabnormalitiesinenergyexpenditureandleanmassinmetabolicdisease
AT chatterjeevk approachtoquantifyingabnormalitiesinenergyexpenditureandleanmassinmetabolicdisease
AT savagedb approachtoquantifyingabnormalitiesinenergyexpenditureandleanmassinmetabolicdisease
AT murgatroydpr approachtoquantifyingabnormalitiesinenergyexpenditureandleanmassinmetabolicdisease